While the experimental modeling data reported here is consistent with a role for TIAM1 and RAC1 in the development of clinical BPH, it is recognized that the bioinformatic analysis of clinical BPH data has several inherent limitations. This evidence concerns the gene RAC1 and benign prostatic hyperplasia.